Glass House Brands has applied to register certain California-licensed medical marijuana operations with the U.S. Drug Enforcement Administration (DEA), following the recent move to reschedule medical marijuana to Schedule III under the federal Controlled Substances Act. The company announced Wednesday that it submitted applications under the expedited registration pathway established by DEA as part of …
Curaleaf Reports $324 Million in Quarterly Revenue, $70 Million in Net Income
Curaleaf reported $324.2 million in revenue for the first quarter of 2026, a 6% increase from the same period last year, while also posting $70.1 million in net income from continuing operations. The company, one of the largest marijuana operators in the U.S. and international markets, said first-quarter revenue was up from $306.6 million in …
The 20 Most Popular Cannabis Strains in the United States as of May 2026
Using data from the strain review site Leafly, the research firm Headset, state regulatory commissions and recent market-tracking reports, the following list highlights 20 of the most popular cannabis strains in the United States as of May 2026. Blue Dream Blue Dream remains one of the most widely recognized and commercially resilient strains in the …
U.S. Senate Banking Committee Chair Tim Scott Says Congress Must Act on Marijuana Banking
U.S. Senator Tim Scott (R-SC), who chairs the Senate Banking, Housing, and Urban Affairs Committee, says Congress will need to act before marijuana businesses can gain reliable access to the federal banking system, even with the Trump administration moving to reschedule marijuana. Speaking Tuesday during an appearance aired by C-SPAN, Scott said federal lawmakers still …
Marijuana Policy Project Releases Pennsylvania Cannabis Voter Guide Ahead of May 19 Primary
The Marijuana Policy Project has released a Pennsylvania cannabis voter guide ahead of the state’s May 19 primary election, offering voters a district-by-district look at where legislative candidates stand on legalizing marijuana. The guide covers candidates running for the Pennsylvania House and Senate, with every House seat and half of the Senate on the ballot …
Study: Combining CBD With Ketogenic Diet May Reduce Seizures in Patients With Pharmacoresistant Epilepsy
A study published today in Epilepsy Research found that combining CBD with ketogenic diet therapy can reduce seizures in patients with pharmacoresistant epilepsy, particularly when the diet is added after CBD treatment has already begun. Researchers from The Johns Hopkins University School of Medicine conducted a retrospective chart review of 58 people with epilepsy who …
California Cannabis Sales Reach $311 Million in April, Bringing 2026 Total to $1.2 Billion
California’s legal cannabis market generated $311,089,042 in sales in April, bringing the state’s year-to-date total to roughly $1.21 billion, according to data from the research firm Headset. This resulted in around $180 million in tax revenue. The April total follows $310,443,862 in January, $277,545,874 in February and $306,342,409 in March. Combined, licensed cannabis retailers in …
Arkansas Medical Marijuana Patient Count Reaches 115,501
Arkansas now has 115,501 active medical marijuana patients, according to new data released by the state’s Department of Health. According to updated figures from the Arkansas Department of Health, the state had 115,501 active medical marijuana patients as of May 2. That’s an increase of 226 from the roughly 115,275 active patients reported in March, …
Over 100 of the Most Notable Cannabis Studies Published So Far in 2026
Hundreds of peer-reviewed cannabis-related studies have been published already in 2026, highlighting the continued growth of scientific interest in marijuana, cannabinoids, hemp and the endocannabinoid system. The studies cover a wide range of topics, including cancer, chronic pain, inflammation, neurological disorders, addiction, HIV, metabolic health, veterinary medicine, product testing, cultivation and industrial hemp uses. Many …
Study: CBD Reduces Inflammation in Canine Mammary Cancer Cells
Researchers from the University of Messina found that cannabidiol (CBD) reduced inflammation in canine mammary carcinoma cells without harming cell viability, suggesting it may have therapeutic potential for one of the most common cancers affecting female dogs. The study was conducted by researchers from the Department of Veterinary Science and the Department of Chemical, Biological, …
Sponsored
